David Israeli

11.5k total citations · 2 hit papers
56 papers, 4.3k citations indexed

About

David Israeli is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, David Israeli has authored 56 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 15 papers in Genetics and 8 papers in Oncology. Recurrent topics in David Israeli's work include Muscle Physiology and Disorders (21 papers), RNA Research and Splicing (10 papers) and Virus-based gene therapy research (8 papers). David Israeli is often cited by papers focused on Muscle Physiology and Disorders (21 papers), RNA Research and Splicing (10 papers) and Virus-based gene therapy research (8 papers). David Israeli collaborates with scholars based in France, Israel and United States. David Israeli's co-authors include Alon Harmelin, Moshe Oren, Jotham Suez, Niv Zmora, Tal Korem, Eran Elinav, Shlomit Gilad, Christoph A. Thaiss, Ilana Kolodkin‐Gal and Zamir Halpern and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

David Israeli

54 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial sweeteners induce glucose intolerance by altering the gut microbiota

2014 1.5k citations Jotham Suez, Tal Korem et al. Nature profile →
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs

1998 704 citations Sylvia Wilder, David Israeli et al. profile →

Peers

Countries citing papers authored by David Israeli

Since Specialization

Citations

This map shows the geographic impact of David Israeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Israeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Israeli more than expected).

Fields of papers citing papers by David Israeli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Israeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Israeli. The network helps show where David Israeli may publish in the future.

Co-authorship network of co-authors of David Israeli

This figure shows the co-authorship network connecting the top 25 collaborators of David Israeli. A scholar is included among the top collaborators of David Israeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Israeli. David Israeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	La microdystrophine pour le traitement de la dystrophie musculaire de Duchenne 2024 ·médecine/sciences ·(unknown), (unknown), (unknown), Isabelle Richard, David Israeli	0
2	Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy 2022 ·International Journal of Molecular Sciences ·Nathalie Bourg, (unknown), William Lostal, (unknown), Nicolas Guerchet, (unknown), (unknown), (unknown), Christophe Georger, Nathalie Danièle, Isabelle Richard, David Israeli	9
3	Deciphering the Molecular Mechanism of Incurable Muscle Disease by a Novel Method for the Interpretation of miRNA Dysregulation 2022 ·Non-Coding RNA ·David Israeli, (unknown), Guillaume Corre, (unknown), Isabelle Richard	2
4	A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy 2021 ·European Journal of Translational Myology ·(unknown), (unknown), Isabelle Richard, David Israeli	7
5	miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy 2020 ·Scientific Reports ·(unknown), (unknown), Emmanuelle Massouridès, Nathalie Bourg, Laurence Suel, Fatima Amor, Guillaume Corre, Paule Bénit, Inès Barthélémy, Stéphane Blot, Anne Bigot, Christian Pinset, Pierre Rustin, Laurent Servais, Thomas Voït, Isabelle Richard, David Israeli	20
6	An AAV-SGCG Dose-Response Study in a γ-Sarcoglycanopathy Mouse Model in the Context of Mechanical Stress 2019 ·Molecular Therapy — Methods & Clinical Development ·David Israeli, Jérémie Cosette, Guillaume Corre, Fatima Amor, Jérôme Poupiot, Daniel Stockholm, Marie Montus, Bernard Gjata, Isabelle Richard	21
7	Behavioral and Neural Mechanisms of Overgeneralization in Anxiety 2016 ·Current Biology ·Offir Laufer, David Israeli, Rony Paz	82
8	Perceptual learning in autism: over-specificity and possible remedies 2015 ·Nature Neuroscience ·(unknown), David Israeli, Nancy J. Minshew, Yoram Bonneh, David J. Heeger, Marlene Behrmann, Dov Sagi	48
9	Serum Profiling Identifies Novel Muscle miRNA and Cardiomyopathy-Related miRNA Biomarkers in Golden Retriever Muscular Dystrophy Dogs and Duchenne Muscular Dystrophy Patients 2014 ·American Journal Of Pathology ·Laurence Jeanson-Leh, (unknown), (unknown), (unknown), Fatima Amor, Caroline Le Guiner, Inès Barthélémy, Laurent Servais, Stéphane Blot, Thomas Voit, David Israeli	66
10	Artificial sweeteners induce glucose intolerance by altering the gut microbiota breakdown → 2014 ·Nature ·Jotham Suez, Tal Korem, David Zeevi, Gili Zilberman-Schapira, Christoph A. Thaiss, (unknown), David Israeli, Niv Zmora, Shlomit Gilad, Adina Weinberger, Yael Kuperman, Alon Harmelin, Ilana Kolodkin‐Gal, Hagit Shapiro, Zamir Halpern, Eran Segal, Eran Elinav	1459
11	The Drosophila blood brain barrier is maintained by GPCR-dependent dynamic actin structures 2011 ·The Journal of Cell Biology ·(unknown), Vera Shinder, David Israeli, Frank Schnorrer, Talila Volk	62
12	DNAJB2 Expression in Normal and Diseased Human and Mouse Skeletal Muscle 2010 ·American Journal Of Pathology ·Kristl G. Claeys, (unknown), Jean‐Jacques Martin, Emmanuelle Lacène, (unknown), Daniel Stockholm, Pascal Laforêt, B. Eymard, Antoine Kichler, Daniel Scherman, Thomas Voit, David Israeli	18
13	Real-time monitoring of cell transplantation in mouse dystrophic muscles by a secreted alkaline phosphatase reporter gene 2009 ·Gene Therapy ·Xavier Gérard, (unknown), Séverine Charles, Christian Pinset, Daniel Scherman, Antoine Kichler, David Israeli	7
14	FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation 2008 ·Journal of Cellular Physiology ·(unknown), И. В. Кириллова, Robert E. Richard, David Israeli, Zipora Yablonka‐Reuveni	24
15	Expression of mdr1 is required for efficient long term regeneration of dystrophic muscle 2007 ·Experimental Cell Research ·David Israeli, (unknown), Bernard Gjata, Rachid Benchaouir, Philippe Rameau, Thibaut Marais, So‐ichiro Fukada, Masashi Segawa, Hiroshi Yamamoto, Patrick Gonin, Olivier Danos, Luis Garcı́a	3
16	The c- fos Proto-Oncogene Is a Target for Transactivation by the p53 Tumor Suppressor 1999 ·Molecular and Cellular Biology ·Adi Elkeles, Tamar Juven‐Gershon, David Israeli, Sylvia Wilder, Amir Zalcenstein, Moshe Oren	58
17	Computerised dystrophic muscle simulator: prospecting potential therapeutic strategies for muscle dystrophies using a virtual experimental Model 1999 ·The Journal of Gene Medicine ·Luis Garcı́a, Elise Peltékian, Christian Pastoret, David Israeli, (unknown), Elaine P. Parrish	3
18	Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1and results in apoptosis and tumor suppression 1998 ·Nature Medicine ·Jean-Pierre Roperch, (unknown), Sylvie Prieur, Marcel Tuynder, Mona Nemani, (unknown), (unknown), Marie‐Claude Gendron, David Israeli, J Dausset, Moshe Oren, Robert Amson, Adam Telerman	151
19	Partial sequencing of the rat steroidogenic acute regulatory protein message from immortalized granulosa cells: regulation by gonadotropins and isoproterenol 1996 ·Molecular and Cellular Endocrinology ·N. Selvaraj, David Israeli, Abraham Amsterdam	23
20	Numerous candidate plasticity-related genes revealed by differential cDNA cloning 1993 ·Nature ·Elly Nedivi, (unknown), Dorit Naot, David Israeli, Yoav Citri	426

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact